{"filing":{"accession_number":"0001640334-26-000973","cik":"0001621221","ticker":"ARTL","company_name":"ARTELO BIOSCIENCES, INC.","form":"8-K","filing_date":"2026-05-27","report_date":null,"primary_document":"artl_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000973/artl_8k.htm"},"events":[{"id":8871,"run_id":7789,"accession_number":"0001640334-26-000973","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Artelo Biosciences entered into an At-The-Market (ATM) Offering Agreement on May 26, 2026, authorizing the sale of up to $6,530,000 of common stock through H.C. Wainwright \u0026 Co. under an effective Form S-3 shelf registration.","company_name":"ARTELO BIOSCIENCES, INC.","ticker":"ARTL","filing_date":"2026-05-27","submitted_at":null,"items":[{"id":2085,"accession_number":"0001640334-26-000973","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Artelo Biosciences entered into an At-The-Market (ATM) Offering Agreement on May 26, 2026, authorizing the sale of up to $6,530,000 of common stock through H.C. Wainwright \u0026 Co. This is a dilutive equity issuance under an effective Form S-3 shelf registration. ATM offerings are a classic signal of capital-raising activity at small- and mid-cap issuers and would materially affect investor assessment of share dilution and the company's financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:40:24.386462+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":8872,"run_id":7789,"accession_number":"0001640334-26-000973","anchor_item_number":"8.01","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.95,"summary":"Craft Capital Management LLC filed a FINRA arbitration claim against the Company seeking approximately $1.76 million in success fees and warrant value, plus additional equitable relief and attorneys' fees, arising from an alleged breach of contract related to an $11 million private placement transaction.","company_name":"ARTELO BIOSCIENCES, INC.","ticker":"ARTL","filing_date":"2026-05-27","submitted_at":null,"items":[{"id":2086,"accession_number":"0001640334-26-000973","item_number":"8.01","item_title":"Other Events.","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.95,"reasoning":"Craft Capital Management LLC filed a FINRA arbitration claim against the Company seeking compensatory damages, equitable relief, and attorneys' fees totaling approximately $1.76 million in success fees and warrant value, plus additional relief. This is a material litigation disclosure under Item 8.01 involving a significant financial claim arising from an alleged breach of contract related to a $11 million private placement transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:40:24.386462+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2085,"accession_number":"0001640334-26-000973","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Artelo Biosciences entered into an At-The-Market (ATM) Offering Agreement on May 26, 2026, authorizing the sale of up to $6,530,000 of common stock through H.C. Wainwright \u0026 Co. This is a dilutive equity issuance under an effective Form S-3 shelf registration. ATM offerings are a classic signal of capital-raising activity at small- and mid-cap issuers and would materially affect investor assessment of share dilution and the company's financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:40:24.386462+00:00","company_name":"ARTELO BIOSCIENCES, INC.","ticker":"ARTL","filing_date":"2026-05-27"},{"id":2086,"accession_number":"0001640334-26-000973","item_number":"8.01","item_title":"Other Events.","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.95,"reasoning":"Craft Capital Management LLC filed a FINRA arbitration claim against the Company seeking compensatory damages, equitable relief, and attorneys' fees totaling approximately $1.76 million in success fees and warrant value, plus additional relief. This is a material litigation disclosure under Item 8.01 involving a significant financial claim arising from an alleged breach of contract related to a $11 million private placement transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:40:24.386462+00:00","company_name":"ARTELO BIOSCIENCES, INC.","ticker":"ARTL","filing_date":"2026-05-27"}]}